Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly
Clinical trial NCT05433922 · UNKNOWN
Trial details
- NCT number
- NCT05433922
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-12-31
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.